One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Innovations in Targeting the V2 Receptor.
doi : 10.1681/ASN.0000000601
Volume 36(2) pgs. 163-330 February 2025
A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.
doi : 10.1681/ASN.0000000505
Targeting Kruppel-Like Factor 2 as a Novel Therapy for Glomerular Endothelial Cell Injury in Diabetic Kidney Disease.
Production of Acetylcholine by Podocytes and its Protection from Kidney Injury in GN.
Numerical Flow Simulations of the Shear Stress Forces Arising in Filtration Slits during Glomerular Filtration in Rat Kidney.
doi : 10.1681/ASN.0000000513
Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD.
doi : 10.1681/ASN.0000000502
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses.
Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease-MUC1 27dupC Pathogenic Variant through Exome Sequencing.
doi : 10.1681/ASN.0000000503
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype.
Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.
doi : 10.1681/ASN.0000000501
Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease.
doi : 10.1681/ASN.0000000585
Immigration Status Checks, Emergency Medicaid Utilization, and Health Care Access for Uninsured Individuals with Kidney Disease.
doi : 10.1681/ASN.0000000589
Harnessing Evolution and Biomimetics to Enhance Planetary Health: Kidney Insights.
doi : 10.1681/ASN.0000000582
Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence.
doi : 10.1681/ASN.0000000552
Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence.
doi : 10.1681/ASN.0000000553
Premature Conclusion that Sodium-Glucose Cotransporter-2 Inhibitors Improve Kidney Outcomes in Patients with Heart Failure.
doi : 10.1681/ASN.0000000527
Using VNtyper from Whole Exome Sequencing Data to Detect Pathogenic Variants in the MUC1 Gene.
doi : 10.1681/ASN.0000000574
Authors' Reply: Using VNtyper from Whole Exome Sequencing Data to Detect Pathogenic Variants in the MUC1 Gene.
doi : 10.1681/ASN.0000000575
